Kronos Bio, Inc. financial metrics

Professional SEC-based dashboard for profitability, financial health, and growth with transparent scoring logic. Latest period: Q1 2025.

Location
San Mateo, CA
Fiscal year end
31 December
Latest financial report
08 May 2025

Quick Takeaways

  • Kronos Bio, Inc. financial facts are built from SEC company filings data.
  • Latest metrics period on this page: Q1 2025.
  • Headline metric: Return On Equity -59%.

What Changed

  • Return On Equity YoY change: <span class="text-red-600">-7.3%</span>.
  • Most recent SEC facts end date: 31 Mar 2025.

Why This Matters

  • This gives a beginner-friendly first read before you inspect detailed formulas and metric tables.
  • Every metric card links to a deeper SEC-backed history page for verification.

Source Evidence

Based on latest 10-Q/10-K

Facts and ratios are grounded in SEC company facts linked to the latest 10-Q/10-K cycle.

See Original Filing

Latest SEC snapshot (2025-03-31) highlights Return On Equity -59.5%, Return On Assets -44.3%, and Operating Margin -765.2%.

Financial Quality Score

Transparent 0-100 scoring model based on profitability, financial health, and growth factors.

43.8/100

Caution Confidence medium

Return On Equity

-59%

Metric score 0.0/100

Return On Assets

-44%

Metric score 0.0/100

Financial Health

Current Ratio
12.93x
Debt to Equity
0.36x

Strengths

Debt-to-equity, Revenues YoY, and NetIncomeLoss YoY

Watchpoints

Return On Equity, Return On Assets, and Operating Margin

Key metrics snapshot

Return On Equity

-59%

YoY: -7.3%

Industry median: -43% (n=675)

View history

Return On Assets

-44%

YoY: -10%

Industry median: -47% (n=673)

View history

Operating Margin

-765%

YoY: -54%

Industry median: -121% (n=298)

View history

Current Ratio

12.93x

YoY: +55%

Industry median: 3.39x (n=667)

View history

Debt-to-equity

0.36x

YoY: +13%

Industry median: 0.26x (n=530)

View history

Revenues YoY

21%

YoY:

Industry median: 7.3% (n=302)

View history

NetIncomeLoss YoY

45%

YoY:

Industry median: -0.93% (n=641)

View history

Profitability

Metric Latest value YoY change
Return On Equity -59% -7.3%
Return On Assets -44% -10%
Operating Margin -765% -54%

Financial Health

Metric Latest value YoY change
Current Ratio 12.93x +55%
Debt-to-equity 0.36x +13%

Growth

Metric Latest value YoY change
Revenues YoY 21%
NetIncomeLoss YoY 45%

Share Metrics

Metric Latest value YoY change
Entity Common Stock, Shares Outstanding 60,969,214 +1.5%
Common Stock, Shares, Outstanding 60,969,000 +1.5%
Common Stock, Value, Issued $61,000 +1.7%
Weighted Average Number of Shares Outstanding, Basic 60,807,000 +2.2%
Weighted Average Number of Shares Outstanding, Diluted 60,807,000 +2.2%

Additional Metrics

Metric Latest value YoY change
Revenue from Contract with Customer, Excluding Assessed Tax $9,192,000 +21%
Research and Development Expense $36,558,000 -54%
General and Administrative Expense $23,232,000 -36%
Operating Income (Loss) $70,335,000 +44%
Nonoperating Income (Expense) $5,850,000 -36%
Income Tax Expense (Benefit) $0
Earnings Per Share, Basic -1 +46%
Earnings Per Share, Diluted -1 +46%
Cash and Cash Equivalents, at Carrying Value $91,577,000 +98%
Assets, Current $101,873,000 -36%
Property, Plant and Equipment, Net $1,081,000 -87%
Operating Lease, Right-of-Use Asset $3,048,000 -78%
Other Assets, Noncurrent $112,000 -81%
Assets $108,140,000 -41%
Accounts Payable, Current $1,570,000 -29%
Employee-related Liabilities, Current $148,000 -85%
Contract with Customer, Liability, Current $0 -100%
Liabilities, Current $7,879,000 -59%
Operating Lease, Liability, Noncurrent $20,449,000 -16%
Liabilities $28,328,000 -38%
Accumulated Other Comprehensive Income (Loss), Net of Tax $0
Retained Earnings (Accumulated Deficit) $603,304,000 -12%
Stockholders' Equity Attributable to Parent $79,812,000 -42%
Liabilities and Equity $108,140,000 -41%
Share-based Payment Arrangement, Noncash Expense $500,000 -89%
Net Cash Provided by (Used in) Operating Activities $12,842,000 +46%
Net Cash Provided by (Used in) Financing Activities $0
Net Cash Provided by (Used in) Investing Activities $19,848,000 +244%
Common Stock, Shares Authorized 200,000,000 0%
Common Stock, Shares, Issued 60,969,000 +1.5%
Common Stock, Par or Stated Value Per Share 0 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $7,006,000
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $93,603,000 +94%
Operating Lease, Liability $24,089,000 -12%
Payments to Acquire Property, Plant, and Equipment $0 -100%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $64,436,000 +44%
Lessee, Operating Lease, Liability, to be Paid $30,787,000 -16%
Property, Plant and Equipment, Gross $4,502,000 -72%
Operating Lease, Liability, Current $3,640,000 +21%
Lessee, Operating Lease, Liability, to be Paid, Year Two $4,874,000 -9.8%
Lessee, Operating Lease, Liability, to be Paid, Year One $5,405,000 -8.7%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $6,698,000 -26%
Lessee, Operating Lease, Liability, to be Paid, Year Three $5,020,000 +3%
Preferred Stock, Shares Issued 0
Preferred Stock, Shares Authorized 10,000,000 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four $5,171,000 +3%
Operating Lease, Payments $5,900,000 -3.3%
Additional Paid in Capital $683,055,000 +1.1%
Preferred Stock, Shares Outstanding 0
Depreciation, Depletion and Amortization $220,000 -54%
Share-based Payment Arrangement, Expense $7,035,000 -73%
Preferred Stock, Par or Stated Value Per Share 0 0%

How we score

This score is transparent and deterministic. We weight profitability, financial health, and growth metrics, then renormalize weights when SEC data is missing.

Metric Weight V1 threshold
ROIC205% to 20%
ROE158% to 25%
ROA102% to 10%
Operating Margin55% to 25%
Current Ratio121.0x to 2.0x
Quick Ratio80.8x to 1.5x
Debt to Equity100.3x to 2.0x (lower is better)
Revenue YoY10-10% to +20%
Net Income YoY10-10% to +20%

How Calculated (standard_v1)

Metrics are computed with a market-consensus convention designed for cross-portal comparability.

  • TTM Operating Income / TTM Revenues
  • Current Assets / Current Liabilities (latest instant quarter)
  • (Current Assets - Inventory) / Current Liabilities; fallback: (Cash+Short-Term Investments + Accounts Receivable) / Current Liabilities
  • Total Debt / Stockholders Equity (latest instant quarter; shared unit; freshest series)
  • TTM Net Income / Average Equity (current quarter + same quarter previous year) / 2
  • TTM Net Income / Average Assets (current quarter + same quarter previous year) / 2
  • TTM NOPAT / Average Invested Capital, where NOPAT=Operating Income*(1-tax rate), Invested Capital=Equity+Total Debt-Cash & ST Investments
  • TTM Revenues YoY
  • TTM Net Income YoY